Posted on 6/9/16
3 Reasons Warren Buffett Should Buy CVS Health
IMAGE SOURCE: DONKEYHOTEY VIA FLICKR CREATIVE COMMONS.Warren Buffett is one of the greatest stock pickers of all time. The Oracle of Omaha has made an absolute . . .
Posted on 6/8/16
Twelve Genesis HealthCare Centers Receive Bronze National Quality Award
Genesis HealthCare, one of the nation's largest providers of post-acute care, today announced that 12 of its Centers have been recognized as 2016 recipients of the . . .
Posted on 6/8/16
Boehringer Ingelheim and HealthPrize Partner
Boehringer Ingelheim Pharmaceuticals Inc. and HealthPrize Technologies today announced the launch of RespiPoints™, a free online program that educates, engages, and rewards people who are treating . . .
Posted on 6/8/16
Sarepta Therapeutics Announces Proposed Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (Nasdaq: SRPT), a developer of innovative RNA-targeted therapeutics, today announced that Sarepta, through Credit Suisse and Robert W. Baird & Co., . . .
Posted on 6/8/16
ProEx Physical Therapy Opens 15th New England Clinic in Arlington, MA
ProEx, a physical therapist owned private practice specializing in orthopedics, spine and sports medicine announces the opening
Posted on 6/8/16
Flexion Therapeutics Prices Stock Offering
BURLINGTON, Mass., June 08, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced the pricing of an underwritten public offering of 5,500,000 shares of its . . .
Posted on 6/8/16
Instant Analysis: Biogen's Anti-Lingo-1 Flunks Game-Changing Study In MS
IMAGE SOURCE: BIOGEN INC.What happenedBiogen Inc. (NASDAQ:BIIB) reported today that its next-generation drug, anti-lingo-1, or opicinumab, failed to reverse the effects of multiple sclerosis.Why it mattersOpicinumab . . .
Posted on 6/8/16
3 Reasons Warren Buffett Should Buy CVS Health
IMAGE SOURCE: DONKEYHOTEY VIA FLICKR CREATIVE COMMONS.Warren Buffett is one of the greatest stock pickers of all time. The Oracle of Omaha has made an absolute . . .
Posted on 6/8/16
These Drug Stocks Just Disappointed Investors -- Are They Buys?
IMAGE SOURCE: GETTY IMAGES.Developing game-changing treatments isn't easy. Often drug developers fall short in their efforts and when they do, investors can overreact and send shares . . .
Posted on 6/8/16
3 Biotech Stocks Billionaires Are Buying That I'm Buying, Too
IMAGE SOURCE: FLICKR USER STOCKMONKEYS.COM.Billionaire investors have proven that they can profit in good and bad times, and while no one should blindly follow in the . . .
Posted on 6/8/16
Flexion Therapeutics Announces Proposed Public Offering of Common Stock
BURLINGTON, Mass., June 07, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has commenced an underwritten public offering, subject to market and . . .
Posted on 6/7/16
Metamark Announces Agreement with Anthem Blue Cross Blue Shield of Georgia
Metamark Genetics, Inc., a leader in providing critical diagnostic and prognostic information to enable more informed treatment decisions for urological cancer, today announced that effective May 25, . . .
Posted on 6/7/16
CVS Pharmacy Now Open in Target Stores Throughout Washington
CVS Health (NYSE: CVS) today announced that the first CVS Pharmacy locations in Target stores are now open in Washington. The pharmacies, located in several metropolitan . . .
Posted on 6/7/16
Pronutria Biosciences Relaunches as Axcella Health
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Pronutria Biosciences today announced that it has changed its corporate name to Axcella Health to better reflect its mission of harnessing amino acids for . . .
Posted on 6/7/16
MinuteClinic Expands With New Walk-in Medical Clinics Inside Maryland Target Stores
MinuteClinic, the retail medical clinic of CVS Health, has opened eight new locations inside Target stores in Maryland, including six in the Baltimore metropolitan area. The . . .
Posted on 6/7/16
Why Long-Term Investors Should Prefer Berkshire Hathaway Over Wells Fargo
Don't get me wrong -- Wells Fargo (NYSE:WFC) is one of the best-run banks in the world and still has strong potential for growth. The bank . . .
Posted on 6/7/16
Biogen: It's Time To Buy
In April 2015, I wrote a piece showing how Warren Buffett might look at Biogen (NASDAQ:BIIB). While the numbers for the biotech pharmaceutical company looked good, . . .
Posted on 6/7/16
Berkshire Hathaway Owners Can Pump Up Yields
Subscribers to Income From Covered Option Writing got an advanced preview look at this material.Having your cake and eating it too. It is a classic microcosm . . .
Posted on 6/7/16
Seres Therapeutics Announces Research Collaboration with Mayo Clinic
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc. (NASDAQ:MCRB), a leading microbiome therapeutics platform company, today announced that it has initiated a sponsored research agreement with Mayo Clinic’s Center . . .
Posted on 6/7/16
Moderna Therapeutics and Charles River Laboratories Announce Strategic Collaboration
CAMBRIDGE, Mass. & WILMINGTON, Mass.--(BUSINESS WIRE)--Moderna Therapeutics, a clinical stage pioneer in the development of messenger RNA (mRNA) Therapeutics™ and Charles River Laboratories International, Inc. (NYSE:CRL), . . .
Posted on 6/6/16
Forget Biogen: These 3 Stocks Are Better Buys
Biogen (NASDAQ:BIIB) is a great company, even though it's hit hard times lately since the revelations that the company's biggest blockbuster, Tecifdera, might cause progressive multifocal . . .
Posted on 6/5/16
Strata Oncology Raises $12M Series A and Signs Strategic Partnership with Thermo Fisher Scientific
Strata Oncology, a precision medicine company, today announced the completion of a Series A financing of $12M
Posted on 6/5/16
Ironwood Pharmaceuticals Closes U.S. Transaction with AstraZeneca for Lesinurad
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) announced today that it has closed the previously-announced transaction with AstraZeneca for the exclusive U.S. rights to all products . . .
Posted on 6/5/16
OvaScience Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
WALTHAM, Mass.--(BUSINESS WIRE)--OvaScienceSM (NASDAQ: OVAS), a global fertility company focused on the discovery, development and commercialization of new treatment options, today announced the grant of an . . .
Posted on 6/5/16
Foundation Medicine and AstraZeneca Enter Strategic Collaboration
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc. (NASDAQ:FMI) and AstraZeneca today announced that they have entered into a definitive agreement to develop a novel companion diagnostic assay for . . .
Boston
